chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He got his vaccine, had extreme itching on his arms and legs.  He did call his doctor and talked to the person who gave the shot about 5 days later as they did not realize it was related to the shot.   They felt that it would go away but it has not gotten any better and has probably gotten worse.  They told him it was a normal reaction for a week to 10 days.  They told him to take Benadryl and put antiitch cream on it, which he has been doing.  He operates heavy machinery during the day so cannot do that, can only take at night and that's when it bothers him the most and sometimes at 3:00 AM he has to get up and reapply cream and take more Benadryl.   They called the clinic back and he has an appointment to see his PCP today.
SHE CALLED AT 2P ON 3/14/18 AND ASKED IF LIVER PAIN IS A SIDE EFFECT OF THIS MEDICATION. SAID HER RIGHT SIDE UNDER THE RIBS IS ACHING AND HAS BEEN SINCE LAST NIGHT.
Approx. 1-2 days after shots, had achiness that lasted 3 days.  Then on 7th day had a flushed feeling on the face and body. Also felt itchy and crawly. Took Benadryl then went to ER on 01-04-2006 early AM.  Was given IV Steroids.  Spoke with client and asked if had started on any new meds or had new foods.  Stated she had been taking Niacin(B-3) for approx.1-2 weeks.  Niacin can cause flushing even with normal doses. States her sister had a similar reaction to B-12.
red circle on the arm until 19Apr2021; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (red circle on the arm until 19Apr2021) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No medical history was reported by reporter.  Concomitant products included HCTZ for Blood pressure, CITALOPRAM for Depression, METFORMIN and DULAGLUTIDE (TRULICITY) for Diabetes, LEVOTHYROXINE for Thyroid therapy.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle on the arm until 19Apr2021). On 19-Apr-2021, VACCINATION SITE ERYTHEMA (red circle on the arm until 19Apr2021) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were reported.    Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: No new information
Information has been received from a physician concerning a female pt who was vaccinated with hep b vaccine recombinant. Subsequently the pt experienced mild fever, myalgia, arthralgia and malaise which lasted several days and cleared without complication. Unspecified medical attention was sought. Additional info has been requested.
My resting heart rate increased from 75/76 to 85-90 and has remained that way for over 6 weeks. My V02 max has gone from 36 (very good) to 24 (poor). It has remained this way for over 6 weeks. My doctor says to rest, no exercise and limit caffeine for 3-6 months until it goes back to normal.
Pt received flu shot on 10/14/1999, developed severe cough 10/29, was coughing up blood on 10/30. Was hospitalized 10/30 and received transfusion on 10/31. Tests were conducted and he was referred on 11/14. Pt died on 12/23/99.
soreness that can't be touched without hurting; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (soreness that can't be touched without hurting) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced INJECTION SITE PAIN (soreness that can't be touched without hurting). At the time of the report, INJECTION SITE PAIN (soreness that can't be touched without hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Patient was given an accidental extra dose of VARIVAX on 6/27/13. It was discovered that she was given a PROQUAD and separate VZV when vaccine counts did not add up. Grandmother and CDC were called and she was advised to watch for increased reaction. She was seen on 6/28/13 for redness at injection site 2cm diameter. She was told to start KEFLEX (250/5) 4.5 ml PO TID x 10 days if persists after cool compress. She was to follow up 7/2/13 but canceled stating pt was better.
Pt said her arm was red and hot to the touch from the shoulder where she received the vaccine down to her elbow. Started to bother her that evening after getting the vaccine.
Pt received Td Vaccine on 6/25/16 and the following day had swollen, red, painful (3x2in) site at injection on (R) deltoid. Pt developing other symptoms including fever. Pt had been treating it yesterday with ice. Pt will start warm pack and acetaminophen for resolution. Pt will report back if no improvement or worsens.
ACHES AND PAINS; HEADACHE; This spontaneous report received from a consumer concerned a 53 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 15-MAR-2021, the subject experienced aches and pains. On 15-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from aches and pains, and headache on 18-MAR-2021. This report was non-serious.
Vaccine was administered with a vial that was punctured or more than 12 hrs. Patient reported sore arm.
day after shot.  12hrs of tiredness, light headache and lots of body aches, soreness at injection site
Headache, Myalgia, Arthralgia, Diarrhea, chills temp 99.5 Narrative:
Myalgia, Arthralgia, Fever, DAY 2 AND 3 AFTER INJECTION, PT EXPERIENCED CHILLS, BODY ACHES, AND BONE PAIN Narrative:  Other Relevant History:
24 hours after injection had hives on face, loud rushing sounds in ears, respiratory distress. Took benedryl and had epi pen ready but never had to administer it. Severe symptoms lasted 3 hours, went to dr next day and began steroids. Unsure if I was exposed to another allergen during the 24 hours but determined it was possible. Had 7 days of severe allergic response side effects of brain fog, loud rushing heart beat  noise in head, hives, sensitivity to all allergens , swollen face
On 9/20 patient came to pharmacy with redness, pain, and swelling in right arm between shoulder and elbow. Arm was hot to the touch. Patient said it was very painful and she was unable to sleep last night. She stated that she had body chills as well. Patient said the arm had been more swollen last night and swelling and pain was getting better. I told her if it did not get better or got any worse to got to Medical Doctor for treatment.
rash all over her body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash all over her body). At the time of the report, RASH (rash all over her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 23-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash all over her body). At the time of the report, RASH (rash all over her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
facial swelling; inflammation; This is a spontaneous report received from a contactable consumer. This consumer reported for 16-year-old female patient (reporter's daughter) who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unknown date in 2021 (at 16-year-old), as dose 1, single for COVID-19 immunization. The patient's medical history included COVID-19 (Dec2020) and Seizures (Dec2020), mast cell syndrome that she has since she was 20-year-old and Mast cell syndrome. The patient's concomitant medications were not reported. On an unknown date in 2021 the patient experienced facial swelling and inflammation. Callers daughters reaction occurred a few hours after the vaccination. The daughters face swelled from her eye down to the mouth area on the left side and the mothers lip blew up. Mother did have her histamine levels checked by her HCP and they were noted to be high. Caller stated that what she was trying to figure out at this time is whether or not she/her daughter should receive the 2nd dose of the vaccine after a reaction from the 1st dose. Mother states that she has received no guidance/direction from her provider or the health department regarding this concern. She states she does not know what to do and states it is our immune system going wonky. Caller understands that an allergic reaction was something that happens fast after the vaccine but questions could it happen later. She stated that she knows the vaccine caused the swelling but only because our systems are over powering themselves. The 16-year-old daughter wants to get her 2nd dose because she is tired of getting quarantined due to close contact. She is tired of having her life uprooted because of it. The patient had not recovered. Reporter's daughter's second vaccination was around 02Sep, she takes birth control because of seizures around ovulation. She ovulated after second vaccine, causing her birth control to not work properly.  The lot number for the vaccine, [Pfizer-BioNTech COVID-19 Vaccine], was not provided and will be requested during follow up.
some shoulder joint pain, mostly in right shoulder; minor discomfort at injection site; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3302), via an unspecified route of administration, administered in the left arm  on 11Feb2021 as a single dose for covid-19 immunization. The patient's medical history included high blood pressure from an unknown date and unknown if ongoing. Patient has no allergies to medications, food, or other products. Concomitant medications included atenolol; losartan; aspirin [acetylsalicylic acid] (ASPIRIN); cyanocobalamin (B12); and colecalciferol (D3) all taken for an unspecified indication, start and stop date were not reported. The patient experienced some shoulder joint pain, mostly in right shoulder (non-injection shoulder) and minor discomfort at injection site on 11Feb2021 19:00. Patient was not treated for the events. The outcome of the event was recovered on an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with Covid-19 prior to vaccination and has not been tested for COVID-19 since the vaccination.
The patient had an abdominal ultrasound, which showed no evidence of intussusception but they did note that there was some hydronephrosis of her left kidney. The child has not had a previous history of UTI, but with discussion with mom she believes that this was noted in utero as well. We did send a urine. We had to wait some time for a bag urine had leaked, so she was actually catheterized., the urine was negative. Since her arrive to the emergency room, the patient was able to tolerate some P.O. and was resting comfortably. She had no further episodes of irritability. Is for the mom to go home with the infant and have her follow up on Tuesday with her primary doctor. She is to return sooner if there is any increasing abdominal pain, changes in the child's stool or not taking P.O. We did discuss that workup of the left hydronephrosis will need to be done as an outpatient. The etiology of this child's presentation is likely a viral syndrome, which I explained to the patients. But the plan is that they will follow up with her outpatient provider or sooner to the emergency room if there is changes in her clinical status.
Sven days after the 1st shot I experienced swollen, welt, itchiness  at the injection site.
Fever, vomiting, runny nose, sore throat decreased appetite, maculopapular rash.
Patient had mowed yard + weed eater work before receiving Pneumonia + Flu shots. Was no problem during waiting period at vaccination site. After patient drove home, he got out of truck, got dizzy and fainted. Awoke unharmed. Did more yardwork.
Bronchitis; all over body rash; Dose 1: 29Mar2021; Dose 2: 19May2021; This is a spontaneous report from a contactable consumer (patient).   A 53-years-old female patient reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route, administered in arm left on 19May2021 (age at vaccination was 53 years) as dose 2, single for covid-19 immunization at other facility. The patient was not pregnant at the time of vaccination. Other medications received within 2 weeks of vaccination was reported as none. Medical history was reported as none. No known allergies were reported. There were no concomitant medications reported. The patient previously received bnt162b2 (Batch/Lot number: er2613), via an unspecified route, administered in arm left on 29Mar2021 at 10:30 AM (age at vaccination was 53 years) as dose 1, single for covid-19 immunization. Patient had Inappropriate schedule of vaccine administered. On 21May2021, the patient experienced bronchitis and all over body rash. The adverse events resulted in visit to doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The report was non-serious. The patient underwent lab tests and procedures which included sars-cov-2 test unknown (Nasal Swab) on an unspecified date. Therapeutic measures taken as a result of the bronchitis and all over body rash included unspecified antibiotics steroids and inhaler. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was tested for COVID-19. Outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected. Information about lot/batch number cannot be obtained.
20OCT96 red area size of a quarter @ site;21OCT96 soreness @ site;22OCT96 redness @ site to elbow;pain & swelling to elbow;
Tongue sores 12 - 24 hours after vaccine; This is a spontaneous report from a contactable pharmacist, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Feb2021 at 10:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation and the patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 15Mar2021 at 10:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation  Medical history included allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Mar2021 the patient experienced tongue sores 12 - 24 hours after vaccine and occurred after each dose. The sores persisted intermittent for weeks following the vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the reported events. The clinical outcome of the event tongue sores was resolved with sequelae on an unknown date in 2021 at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient became warm and flushed within 30 seconds of receiving vaccine. Within 1 minute appeared to be having seizure as arms and neck became tonic.
(L) leg knot on leg at injection site, welt looks like a goose egg, reddened, bruised purplish, blue.
Redness from injection site to below elbow swelling on inside of elbow (sent patient to see doctor).
VASAL SYNCOPE, DEHYDRATION, HYPOGLYCEMIA - SHE HAS BEEN FAINTING REGULARLY AFTER THE SHOT WAS ADMINISTERED, AND IT FIRST HAPPENED BEFORE SHE EVEN LEFT THE DOCTOR'S OFFICE. WE HAVE BEEN SPENDING A LOT OF TIME AT THE DOCTOR'S OFFICE, AND EMERGENCY ROOM.
Long standing hx of myalgia (fibromyagia). with neg Rheum labs. Pt received her first Shingrix vaccine in her right arm on 09OCT2020. No other vaccines have been administered in the past 11 months. That evening, she experienced a local site reaction described as swelling, redness, and pain around the injection site, as well as general malaise.  The next morning she states she was unable to move.  Her husband had to assist her out of bed. He describes her extremities a being stiff (not flaccid).  With movement, there was symmetrical pain in her shoulders, hips, thighs, hands and feet.  Over the next few days, she experienced weakness and pain (with motion) in her pelvic girdle making walking difficult. She recently has begun to use a wheelchair at providers' appointments.  Although she has seemingly FROM of all joints, here ADLs are limited by generalized weakness and pain, principally axially, but also involving her hands and feet.  She has noted some bilateral swelling of hands (and wrists) and ankles as well. There has been no noted warmth or erythema of any joints. These symptoms are most prominent upon awakening in the morning and better, albeit still present, by noon/early afternoon. She has noted mild global headache since vaccination.  She had a recent transient low-grade fever (COVID negative), but denies fevers in the past.  Laboratory evaluation reveals mildly elevated inflammatory markers (ESR/CRP), but little else.  CK, urine myoglobin, CBC. CMP,  COVID, c1q, aldolase all WNL. Started on low dose steroid for 7 days, to f/u Rheum and PCP, follow inflammatory markers
Hives worsening over 2 week period causing lip and face swelling. Also had body ache, fever, and headache for 2 days. Prendison prescribed with Benadryl, follow up appointment in 2 days. If symptoms worsen or trouble breathing or swallowing go to emergency room.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 56-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX vaccine (received other vaccine around October 2017). Concurrent medical conditions included osteoporosis (had the condition for about 2 years) and intervertebral disc protrusion (disk sites at L4, L5 and S1). Concomitant products included PROLIA and vitamin D. On 22nd June 2018, the patient received the 1st dose of SHINGRIX. On 22nd June 2018, several hours after receiving SHINGRIX, the patient experienced pain in arm. On 23rd June 2018, the patient experienced headache, muscle pain, appetite lost, back pain, fatigue, injection site erythema, injection site warmth, fever, influenza like illness, buttock pain, coccydynia and feeling bad. The patient was treated with TYLENOL. On an unknown date, the outcome of the headache, injection site erythema and injection site warmth were recovering/resolving and the outcome of the muscle pain, appetite lost, pain in arm, back pain, fatigue, fever, influenza like illness, buttock pain, coccydynia and feeling bad were not recovered/not resolved. The reporter considered the headache, muscle pain, appetite lost, pain in arm, back pain, fatigue and injection site erythema to be related to SHINGRIX. It was unknown if the reporter considered the injection site warmth, fever, influenza like illness, buttock pain, coccydynia and feeling bad to be related to SHINGRIX. Additional details reported as follows: The patient reported that she decided herself to get the vaccine. The time of administration of the SHINGRIX was sometime between 11:00 AM and 1:00 PM. In the evening the day of vaccination, the patient noticed the soreness in the arm, when she was nudged in the arm. The patient had flu like symptoms (headache, fever, muscle ache and fatigue) first on Saturday morning. The patient looked at her arm at the injection site, the spot was very red and felt like the skin had a fever. The size of the redness on the arm looked like a big circle that covered her upper arm that has spread all around. When the patient went to go to the bathroom that same morning, she could hardly get out of the bed because of the pain she was experiencing. She said the pain was located lower back in the middle of her buttocks and her tail bone. The patient was still experiencing the pain, at the time of reporting. The patient had never felt pain like this before. The patient said that she felt bad on Saturday, but the symptoms got worse on Sunday. She did take some TYLENOL on the reporting morning for her headache and BENADRYL as treatment for possible for more reactions. A suggestion was made to contact her physician about her side effects. The patient had contacted VAERS and left a message for a call back. The patient was asked to make VAERS aware that she had already spoken to the company and filed a report.
Rash localized near injection site, first noticed 9 days after injection.  At that point it was about the size of a quarter and slightly itchy.  Today, two days later, it is about 3? in diameter and moderately itchy.
Shingles on right side of face and in right ear, Sores in ear pain and tingling  and numbness of face on that side. Sores lasted almost a month pain in face still there now. Was treated with two rounds Valacyclovir, one round of Hydrocodone-Acetamin 7.5 - 325, 3 weeks of Ofloxacin .3%,  now on gabapantin100mg 3 times a day for 30 days,Prednisone 20 mg( 5days)
SORE LEFT ARM AT SITE OF SHOT. PAIN RADIATED UP TO LEFT SIDE OF THE NECK, BASE OF HEAD. HEADACHE. VERTIGO AND DIZZINESS WITH NAUSEA. VERTIGO PERSISTENT.